Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential
- PMID: 38490077
- DOI: 10.1016/j.phymed.2024.155503
Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential
Abstract
Background: Natural products have demonstrated significant potential in cancer drug discovery, particularly in renal cancer (RCa), urothelial carcinoma (UC), and testicular cancer (TC).
Purpose: This review aims to examine the effects of natural products on RCa, UC and TC.
Study design: systematic review METHODS: PubMed and Web of Science databases were retrieved to search studies about the effects of natural products and derivatives on these cancers. Relevant publications in the reference list of enrolled studies were also checked.
Results: This review highlighted their diverse impacts on key aspects such as cell growth, apoptosis, metastasis, therapy response, and the immune microenvironment. Natural products not only hold promise for novel drug development but also enhance the efficacy of existing chemotherapy and immunotherapy. Importantly, we exert their effects through modulation of critical pathways and target genes, including the PI3K/AKT pathway, NF-κB pathway, STAT pathway and MAPK pathway, among others in RCa, UC, and TC.
Conclusion: These mechanistic insights provide valuable guidance for researchers, facilitating the selection of promising natural products for cancer management and offering potential avenues for further gene regulation studies in the context of cancer treatment.
Keywords: Natural products; Renal cancer; Signal pathways; Testicular cancer; Urothelial carcinoma.
Copyright © 2024 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have nothing to declare.
Similar articles
-
A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x. Epub 2012 Oct 29. BJU Int. 2012. PMID: 23107319
-
The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.Clin Genitourin Cancer. 2018 Apr;16(2):e269-e276. doi: 10.1016/j.clgc.2017.10.011. Epub 2017 Nov 3. Clin Genitourin Cancer. 2018. PMID: 29199023 Review.
-
Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.Sci Rep. 2015 Aug 4;5:12807. doi: 10.1038/srep12807. Sci Rep. 2015. PMID: 26239046 Free PMC article.
-
Targeting different phenotypes of macrophages: A potential strategy for natural products to treat inflammatory bone and joint diseases.Phytomedicine. 2023 Sep;118:154952. doi: 10.1016/j.phymed.2023.154952. Epub 2023 Jul 12. Phytomedicine. 2023. PMID: 37506402 Review.
-
Emerging therapeutic targets in bladder cancer.Cancer Treat Rev. 2015 Feb;41(2):170-8. doi: 10.1016/j.ctrv.2014.11.003. Epub 2014 Nov 24. Cancer Treat Rev. 2015. PMID: 25498841 Review.
Cited by
-
Clinicopathological Characteristics and Prediction of Postoperative Mortality Risk in Patients with Non-metastatic Sarcomatoid Renal Cell Carcinoma.Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251367123. doi: 10.1177/15330338251367123. Epub 2025 Aug 21. Technol Cancer Res Treat. 2025. PMID: 40836853 Free PMC article.
-
Exploring the role of ADAMTSL2 across multiple cancer types: A pan-cancer analysis and validated in colorectal cancer.Discov Oncol. 2024 Oct 9;15(1):538. doi: 10.1007/s12672-024-01401-6. Discov Oncol. 2024. PMID: 39384622 Free PMC article.
-
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.Chin J Cancer Res. 2024 Dec 30;36(6):596-615. doi: 10.21147/j.issn.1000-9604.2024.06.03. Chin J Cancer Res. 2024. PMID: 39802902 Free PMC article. No abstract available.
-
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease.Adv Sci (Weinh). 2025 Apr;12(13):e2407715. doi: 10.1002/advs.202407715. Epub 2025 Feb 25. Adv Sci (Weinh). 2025. PMID: 40007149 Free PMC article. Review.
-
Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions.Aging Dis. 2024 Mar 27;16(2):645-657. doi: 10.14336/AD.2024.0327. Aging Dis. 2024. PMID: 38607733 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical